CHRS

CHRS Stockholders Equity

$60.84MQuarterly · USD

Period ending:

CHRS FY Shareholders EquityUSD
CHRS FY Shareholders Equity2012-12-31: $9.19M2013-12-31: -$42.38M2014-12-31: $66.76M2015-12-31: -$6.93M2016-12-31: $19.35M2017-12-31: $30.54M2018-12-31: -$38.59M2019-12-31: $105.21M2020-12-31: $280.97M2021-12-31: $97.73M2022-12-31: -$137.42M2023-12-31: -$193.43M2024-12-31: -$131.99M2025-12-31: $61.01M$280.97M-$193.43M
2012-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CHRS stockholders equity history

Net worth of the company (assets minus liabilities). The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.

Coherus Oncology Inc Stockholders Equity — Annual fiscal periods (USD)
Period endingStockholders Equity (USD)
61,014,000
-131,990,000
-193,425,000
-137,418,000
97,726,000
280,974,000
105,214,000
-38,591,000
30,535,000
19,354,000
-6,929,000
66,757,000
-42,382,000
9,192,000

Compare stockholders equity

All CHRS financial metrics · CHRS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.